Commerzbank: Barclays' Deposit Warning Meets UniCredit's Unfinished Paperwork
Published on 10/24/2026 at 21:40 | Editorial boerse-global.de
Two clocks are ticking for Commerzbank shareholders, and they keep different time. One measures regulatory approvals for UniCredit's creeping control of the Frankfurt lender; the other measures whether the bank can still earn a decent spread on deposits in a German market where competition has turned nasty. Confusing the two is the easiest way to misread the stock.
Start with the ownership side, where the headlines have been loudest. Roughly a week ago, the ECB cleared UniCredit to cross the 30% threshold in Commerzbank. According to the Italian group, that permission allows further stake-building with no cap at all. It is a supervisory box ticked — not the finish line. UniCredit expects the remaining approvals to land around the turn of the year, after which it anticipates holding around 50% of Commerzbank's voting rights. That is a company forecast, not a position already on the books. The green light grants room to manoeuvre; how that room gets used, and when the other procedures close, remain open questions.
There is a further date to circle: according to media reports, the EU Commission is due to rule on the deal on 16 November 2026. That sits alongside the ECB nod as a separate checkpoint, and it does not follow automatically from it.
A different yardstick on the operating side
While the takeover machinery grinds on, Barclays turned more guarded on the business itself. As reported in the media, the house cut Commerzbank from "Overweight" to "Equal Weight" on Wednesday, trimming its price target to EUR 41 from EUR 42. Analyst Paola Sabbione pointed to a smaller expected rise in net interest income and tougher deposit competition in Germany. Her caution concerns earnings power, not the state of UniCredit's permissions — so no comfort for the core business can be read across from the stake-building story.
Should investors sell immediately? Or is it worth buying Commerzbank?
Friday's closing price of EUR 36.13 sat below the reduced Barclays target. That gap does not undo the downgrade: target and rating belong together, and quoting the number alone would tell only half the story.
BlackRock's filing says nothing about earnings
A separate disclosure added noise on Thursday. BlackRock reported lower voting rights, with shares-based rights at 3.05% and the position including instruments at 4.33%, down from 4.38%. Those figures describe the size of a reported holding. They carry no signal about how BlackRock views the bank's prospects, and they offer neither a reason to buy nor proof of operational decay. Investors weighing an operational recovery need business numbers; those betting on shifts in the shareholder register must assess that wager on its own terms.
The completed buyback belongs in the same careful framing. Commerzbank repurchased 3,157,027 of its own shares between 12 and 16 October inclusive — an executed transaction, not a statement of intent. It complements the earnings case but cannot stand in for it, and investors should resist treating finished buybacks as automatic evidence of better results to come.
What the two November dates will settle
Commerzbank publishes its third-quarter 2026 results on 5 November 2026, giving shareholders their first chance to test Sabbione's forecast against actual figures. If net interest income rises more convincingly than Barclays expects, the stock could gain an operational argument to set beside the ownership narrative — and the debate would shift from who holds how many votes to what the bank actually earns. If the quarter confirms the cautious view, or undershoots it, deposit competition moves to centre stage, and a stake-building story cannot paper over that disappointment.
Then comes 16 November and the Commission's reported decision, a second, independent test of the control plans. Neither a supervisory clearance nor a single quarter settles the other's question. Anyone building a thesis on UniCredit's expected 50% must carry the earnings risk alongside the risk that the stake develops differently than advertised — approval alone guarantees neither that share of votes nor any particular price reaction.
Until the numbers land, the choice is one of investment case: Commerzbank proving itself on its own earnings, or the reshaping of its owner base taking priority. BlackRock's filing answers neither question. The quarterly report, by contrast, will show how sturdy the operational argument really is.
Ad
Commerzbank Stock: New Analysis - 24 October
Fresh Commerzbank information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
